 Chembio Diagnostics Inc NASDAQ: CEMI has launched the commercial distribution of an FDA-Emergency Use Authorized rapid point-of-care COVID-19 antigen test. Product inventory is on-hand and immediately available for shipment to Chembio customers across the U.S. 